Travere Therapeutics, Inc.
TVTX· Nasdaq
TVTXTravere Therapeutics, Inc.
Filed Sep 16, 2013 · 10-Q · -14 days after period end · 0001193805-13-001602
| Metric | Q3 2013 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | — | $0.00 | $0.00 |
| Net Income | -$12.01M | -$3.52K | -$5.67K |
| EPS Diluted | -$0.71 | -$0.03 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Travere Therapeutics, Inc. · CIK 1438533 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Sep 16, 2013 · -14 d after period end
